Eris Lifesciences Limited (BOM:540596)
India · Delayed Price · Currency is INR 1,352.75
-22.85 (-1.66%)
At close: Jul 31, 2026
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 187.72 billion as of July 31, 2026. Its market cap has decreased by -24.13% in one year.
Market Cap
187.72B
Enterprise Value
210.56B
Revenue
32.12B
Ranking
n/a
PE Ratio
29.15
Stock Price
1,352.75
ChartMarket Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 187.72B, an increase of 126.97%. That is a compound annual growth rate of 9.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 187.72B | -8.47% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 449.51B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 245.64B |
| Granules India | 204.20B |
| AstraZeneca Pharma India | 202.59B |
| Caplin Point Laboratories | 191.15B |
| Jubilant Pharmova | 148.07B |
| CORONA Remedies | 128.36B |